{"id":"https://openalex.org/W7215645504","doi":null,"title":"Mitigative effects of a topically-applied combination of cimifugin and vinpocetine on a murine psoriasis-like model","display_name":"Mitigative effects of a topically-applied combination of cimifugin and vinpocetine on a murine psoriasis-like model","publication_year":2025,"publication_date":"2025-10-10","ids":{"openalex":"https://openalex.org/W7215645504"},"language":"en","primary_location":{"id":"pmh:oai:pharmakeftiki.hsmc.gr:article/134","doi":null,"is_oa":true,"landing_page_url":"https://pharmakeftiki.hsmc.gr/pj/article/view/134","pdf_url":"https://pharmakeftiki.hsmc.gr/pj/article/download/134/71","source":{"id":"https://openalex.org/S7407067120","display_name":"Pharmakeftiki","issn_l":"1105-4999","issn":["1105-4999"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1105-4999","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://pharmakeftiki.hsmc.gr/pj/article/download/134/71","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5153939805","display_name":"Alaa Hamza Abbas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4400573189","display_name":"Al-Mustaqbal University","ror":"https://ror.org/023a3xe97","country_code":"IQ","type":"education","lineage":["https://openalex.org/I4400573189"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Abbas, Alaa Hamza","raw_affiliation_strings":["Department of Pharmacology , College of Pharmacy , Al-Mustaqbal University , Hillah , Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology , College of Pharmacy , Al-Mustaqbal University , Hillah , Iraq","institution_ids":["https://openalex.org/I4400573189"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153889691","display_name":"Zaid M. Hassan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Hassan, Zaid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5154168261","display_name":"Mohammed A. Albarki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Albarki, Mohammed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059198919","display_name":"Qassim A. Zigam","orcid":"https://orcid.org/0000-0002-1425-3450","observed_orcids":["https://orcid.org/0000-0002-1425-3450"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Zigam, Qassim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117101138","display_name":"Hayder Ridha\u2010Salman","orcid":"https://orcid.org/0000-0003-1594-4883","observed_orcids":["https://orcid.org/0000-0003-1594-4883"]},"institutions":[{"id":"https://openalex.org/I4400573189","display_name":"Al-Mustaqbal University","ror":"https://ror.org/023a3xe97","country_code":"IQ","type":"education","lineage":["https://openalex.org/I4400573189"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Ridha-Salman, Hayder","raw_affiliation_strings":["Department of Pharmacology , College of Pharmacy , Al-Mustaqbal University , Hillah , Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology , College of Pharmacy , Al-Mustaqbal University , Hillah , Iraq","institution_ids":["https://openalex.org/I4400573189"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153999699","display_name":"Hasanain A. M. Abbas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. M. Abbas, Hasanain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115826906","display_name":"Maytham Ahmed AbdulAemah","orcid":"https://orcid.org/0000-0002-3333-9778","observed_orcids":["https://orcid.org/0000-0002-3333-9778"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmed AbdulAemah, Maytham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047362857","display_name":"Weaam J. Abbas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Abbas, Weaam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073693526","display_name":"Abdulla K. Raheem","orcid":"https://orcid.org/0000-0001-8181-3879","observed_orcids":["https://orcid.org/0000-0001-8181-3879"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Raheem, Abdulla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042151966","display_name":"Ali Jihad Hemid Al-Athari","orcid":"https://orcid.org/0000-0003-2530-293X","observed_orcids":["https://orcid.org/0000-0003-2530-293X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hemid Al-Athari, Ali Jihad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153706607","display_name":"Zahraa H. Abbas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Abbas, Zahraa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117570307","display_name":"Salim K. Hajwal","orcid":"https://orcid.org/0000-0002-9793-2247","observed_orcids":["https://orcid.org/0000-0002-9793-2247"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Hajwal, Salim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5153768180","display_name":"Mahdi Hamzah Al-Taee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hamzah Al-Taee, Mahdi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cimifugin","display_name":"cimifugin","score":0.9739999771118164},{"id":"https://openalex.org/keywords/vinpocetine","display_name":"vinpocetine","score":1.0},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9539999961853027},{"id":"https://openalex.org/keywords/saposhnikovia-divaricata","display_name":"Saposhnikovia divaricata","score":0.9179999828338623},{"id":"https://openalex.org/keywords/chromones","display_name":"chromones","score":0.7720000147819519},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.7850000262260437},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8799999952316284},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":1.0},{"id":"https://openalex.org/keywords/il-23","display_name":"IL-23","score":0.9980000257492065},{"id":"https://openalex.org/keywords/clobetasol","display_name":"clobetasol","score":0.7450000047683716},{"id":"https://openalex.org/keywords/antipsoriatic-activity","display_name":"antipsoriatic activity","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C2778788455","wikidata":"https://www.wikidata.org/wiki/Q420288","display_name":"Vinpocetine","level":2,"score":0.9984999895095825},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7263000011444092},{"id":"https://openalex.org/C2779112978","wikidata":"https://www.wikidata.org/wiki/Q423417","display_name":"Imiquimod","level":2,"score":0.7074999809265137},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4652999937534332},{"id":"https://openalex.org/C153400128","wikidata":"https://www.wikidata.org/wiki/Q3150731","display_name":"Infiltration (HVAC)","level":2,"score":0.4555000066757202},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.450300008058548},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4408999979496002},{"id":"https://openalex.org/C118995209","wikidata":"https://www.wikidata.org/wiki/Q5636366","display_name":"HaCaT","level":3,"score":0.41620001196861267},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38109999895095825},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.33090001344680786},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.3140999972820282},{"id":"https://openalex.org/C2777928079","wikidata":"https://www.wikidata.org/wiki/Q2677027","display_name":"Rat\u00f3n","level":2,"score":0.30889999866485596},{"id":"https://openalex.org/C3019114686","wikidata":"https://www.wikidata.org/wiki/Q3089676","display_name":"Rat model","level":2,"score":0.2980000078678131},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.2872999906539917},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.250900000333786}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:pharmakeftiki.hsmc.gr:article/134","doi":null,"is_oa":true,"landing_page_url":"https://pharmakeftiki.hsmc.gr/pj/article/view/134","pdf_url":"https://pharmakeftiki.hsmc.gr/pj/article/download/134/71","source":{"id":"https://openalex.org/S7407067120","display_name":"Pharmakeftiki","issn_l":"1105-4999","issn":["1105-4999"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1105-4999","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pharmakeftiki.hsmc.gr:article/134","doi":null,"is_oa":true,"landing_page_url":"https://pharmakeftiki.hsmc.gr/pj/article/view/134","pdf_url":"https://pharmakeftiki.hsmc.gr/pj/article/download/134/71","source":{"id":"https://openalex.org/S7407067120","display_name":"Pharmakeftiki","issn_l":"1105-4999","issn":["1105-4999"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1105-4999","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7215645504.pdf","grobid_xml":"https://content.openalex.org/works/W7215645504.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W2056313774","https://openalex.org/W2791429177","https://openalex.org/W3004915381","https://openalex.org/W4381252508","https://openalex.org/W4401251976","https://openalex.org/W4402389550","https://openalex.org/W4404910248"],"related_works":["https://openalex.org/W4386885144","https://openalex.org/W3034095642","https://openalex.org/W7127857399","https://openalex.org/W7124468099","https://openalex.org/W4400493669","https://openalex.org/W4402192109","https://openalex.org/W4409036292","https://openalex.org/W4391160884","https://openalex.org/W4214544926","https://openalex.org/W4403412920"],"abstract_inverted_index":{"The":[0,54],"chromones":[1],"found":[2],"in":[3,12,214],"the":[4,49,62,99,111,160,169,173,179,195,198,210],"dried":[5],"roots":[6],"of":[7,20,27,51,56,65,69,77,113,148,172,182,197,201,222],"Saposhnikovia":[8,14],"divaricata":[9,15],"include":[10],"cimifugin;":[11],"fact,":[13],"is":[16,23,33],"a":[17,24,66,75,78,133,137,141,146,219],"main":[18],"source":[19],"cimifugin.":[21],"Vinpocetine":[22],"synthetic":[25],"version":[26],"vincamine":[28],"derived":[29],"from":[30],"periwinkle;":[31],"it":[32,41],"characterized":[34],"by":[35,194],"potent":[36],"anti-inflammatory":[37],"properties":[38],"that":[39,178,218],"allow":[40],"to":[42,60],"reduce":[43],"immune":[44],"cell":[45],"infiltration":[46],"and":[47,71,151,184,206,224],"suppress":[48],"release":[50],"pro-inflammatory":[52],"cytokines.":[53],"objective":[55],"this":[57,84],"study":[58],"was":[59],"investigate":[61],"potential":[63],"influence":[64],"topically-applied":[67,180,220],"combination":[68,147,181,221],"cimifugin":[70,138,149,223],"vinpocetine":[72,142,152,225],"gels":[73,186],"on":[74],"model":[76],"psoriasis-like":[79,114],"inflammatory":[80],"skin":[81,115,199],"reaction.":[82],"To":[83],"end,":[85],"we":[86],"divided":[87],"48":[88],"albino":[89],"BALB/c":[90],"mice":[91],"into":[92],"six":[93],"groups.":[94],"All":[95],"groups":[96,128],"except":[97],"for":[98,107,110,157],"negative":[100],"control":[101],"group":[102,118],"received":[103,119],"imiquimod":[104,120],"topically":[105],"(daily,":[106],"7":[108,158,166],"days)":[109],"induction":[112,171],"lesions.":[116,174],"A":[117],"(5%)":[121],"only":[122],"(positive":[123],"control),":[124],"while":[125],"four":[126],"other":[127],"were":[129,163],"also":[130],"treated":[131],"with":[132],"clobetasol":[134],"(0.05%)":[135],"cream,":[136],"(3%)":[139,143,150,153],"gel,":[140,144],"or":[145],"gels,":[154],"once":[155],"daily,":[156],"days;":[159],"aforementioned":[161],"treatments":[162],"first":[164],"applied":[165],"days":[167],"after":[168],"pharmacological":[170],"Our":[175],"findings":[176],"revealed":[177],"cimifugin-":[183],"vinpocetine-containing":[185],"had":[187],"an":[188],"important":[189],"anti-psoriatic":[190,229],"effect,":[191],"as":[192],"seen":[193],"diminishing":[196],"levels":[200],"tumour":[202],"necrosis":[203],"factor-alpha,":[204],"interleukin-17,":[205],"interleukin-23,":[207],"thereby":[208],"improving":[209],"imiquimod-induced":[211],"histological":[212],"changes":[213],"mice.":[215],"We":[216],"conclude":[217],"can":[226],"exert":[227],"substantial":[228],"activity.":[230]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-10-02T00:00:00"}